Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Boeing, Spirit AeroSystems And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Published 14/04/2023, 11:35
© Reuters.  Boeing, Spirit AeroSystems And Other Big Stocks Moving Lower In Friday's Pre-Market Session
BA
-
IXIC
-
BOEI34
-

Benzinga - U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

  • Meta Materials Inc. (NASDAQ: MMAT) shares dropped 20.2% to $0.3050 in pre-market trading after the company reported a proposed public offering.
  • Spirit AeroSystems Holdings, Inc. (NYSE: SPR) dipped 11.6% to $31.46 in pre-market trading. Boeing flagged a delay in deliveries of a significant number of 737 Max jets due to manufacturing issues with its supplier Spirit AeroSystems.
  • Sangamo Therapeutics, Inc. (NASDAQ: SGMO) fell 9.8% to $1.48 in pre-market trading after jumping over 20% on Thursday.
  • Nutex Health Inc. (NASDAQ: NUTX) fell 7.5% to $0.74 in pre-market trading. Nutex Health recently announced it entered into a $100 million pre-paid advance agreement with Yorkville Advisors Global.
  • Lucid Group, Inc. (NASDAQ: LCID) dropped 7.2% to $7.66 in pre-market trading. The company reported first-quarter production and delivery figures, which came in lower than the preceding three months, reported Reuters.
Don’t forget to check out our premarket coverage here

  • The Boeing Company (NYSE: BA) shares declined 5.4% to $201.99 in pre-market trading. The company has stopped deliveries of some 737 MAX over a new supplier quality problem by Spirit AeroSystems Holdings that could go back to 2019, reported Reuters.
  • Teva Pharmaceutical Industries Limited (NYSE: TEVA) dropped 5% to $8.80 in pre-market trading after the company said that the U.S. FDA issued a complete response letter to its partner Alvotech for the Biologics License Application (BLA) for AVT02, a high-concentration biosimilar candidate for Humira®.
  • ViewRay, Inc. (NASDAQ: VRAY) fell 3.8% to $1.76 in pre-market trading. Stifel downgraded ViewRay from Buy to Hold and lowered the price target from $7 to $1.75.
Now Read This: Wells Fargo Likely To Report Higher Q1 Earnings - Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.